Burundi makes significant progress against NTDs

NewsGuard 100/100 Score

In this "End the Neglect" blog post, Alan Fenwick, director of the Schistosomaisis Control Initiative and professor of Tropical Parasitology at Imperial College in London, examines Burundi's progress in combating neglected tropical diseases (NTDs). He writes, "Over a period of four years, interventions to protect people against river blindness, and treatment for those infected with schistosomiasis and intestinal worms were delivered annually through schools and communities," and that, as a result of these efforts which delivered more than 31 million treatments to school children throughout the country, river blindness was eliminated; schistosomiasis prevalence was reduced from 12.7 percent to 1.7 percent; anemia prevalence fell from 25 percent to below 10 percent; and worm prevalence and intensities were significantly reduced (9/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative molecular biology technique used to identify targets for Schistosoma mansoni vaccine candidates